Patent Assignment
Reel/Frame 029017/0877
Notice of Grant of Security Interest in Patents
Recorded: 2012-09-20
Pages: 8
Assignor
SPECTRUM PHARMACEUTICALS, INC.
Executed: 2012-09-05
Assignee
BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
135 S. LASALLE STREET, IL4-135-05-41, CHARLOTTE, NORTH CAROLINA, 28202
Covered Properties
(28)
Carbon Monoxide Dependent Guanylyl Cyclase Modifiers and Methods of Use
Patent:
5,447,939 →
Application:
08/280,719 →
Novel Serotonin-Like 9-Substituted Hypoxanthine and Methods of Use
Patent:
6,303,617 →
Application:
09/304,728 →
Synthesis and Methods of Use of 9-Substituted Guanine Derivatives
Patent:
6,297,226 →
Application:
09/419,153 →
Use of 9-Substituted Hypoxanthine Derivatives to Stimulate Regeneration of Nervous Tissue
Patent:
6,288,069 →
Application:
09/442,151 →
Synthesis and Methods of Use of Tetrahydroindolone Analogues and Derivatives
Methods for Treatment of Drug-Induced Peripheral Neuropathy
Methods for Treatment of Disease-Induced Peripheral Neuropathy and Related Conditions
Methods for Treating Cognitive/Attention Deficit Disorders Using Tetrahydroindolone Analogues and Derivatives
Tetrahydroindolone and Purine Derivatives Linked to Arylpiperazines
Medical Compositions for Intravesical Treatment of Bladder Cancer
Methods for Treating Cognitive/Attention Deficit Disorders Using Tetrahydroindolone Analogues and Derivatives
Rare Earth Metal Compositions for Treating Hyperphosphatemia and Related Methods
Sensitization of Tumor Cells to Radiation Therapy Through the Administration of Endothelin Agonists
Medical Compositions for Intravesical Treatment of Bladder Cancer
Methods and Compositions for Contributing to the Treatment of Cancers
Medical Compositions for Intravesical Treatment of Bladder Cancer
Application:
12/327,781 →
Publication:
US 2009/0076123
Methods, Compositions and Articles of Manufacture for Contributing to the Treatment of Cancers
Methods for Treating Cognitive /Attention Deficit Disorders Using Tetrahydroindolone Analogues and Derivatives
Rare Earth Metal Compounds, Methods of Making, and Methods of Using the Same
Stable Elsamitrucin Salt Formulations
Application:
12/809,575 →
Publication:
US 2011/0251143
Thioxanthone-Based Autophagy Inhibitor Therapies to Treat Cancer
Bladder Cancer Treatment and Methods
Bladder Cancer Treatment and Methods
Application:
13/083,428 →
Publication:
US 2011/0288472
Lanthanum Carbonate Hydroxide, Lanthanum Oxycarbonate and Methods of Their Manufacture and Use
Methods, Compositions and Articles of Manufacture for Contributing to the Treatment of Cancers
Methods and Compositions for Contributing to the Treatment of Cancers
Rare Earth Metal Compounds, Methods of Making, and Methods of Using the Same
Application:
13/229,157 →
Publication:
US 2011/0318410
Methods for Treating Cognitive/Attention Deficit Disorders Using Tetrahydroindolone Analogues and Derivatives
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Release of Security Interest
Jan 17, 2014
From: BANK OF AMERICA, N.A.
To: SPECTRUM PHARMACEUTICALS, INC.
Reel/Frame 031995/0892 →
Assignment of Assignor's Interest
Jun 28, 2021
From: MOERCK, RUDI E.; SPITLER, TIMOTHY MALCOME; SCHAUER, EDWARD A.; PROCHAZKA, JAN
To: ALTAIR NANOMATERIALS INC.
Reel/Frame 056690/0048 →
Change of Name
Jun 28, 2021
From: ALTAIR NANOMATERIALS INC.
To: ALTAIRNANO, INC.
Reel/Frame 056698/0511 →
Quitclaim Patent Assignment with an Effective Date of 9/20/2018
Jun 29, 2021
From: SPECTRUM PHARMACEUTICALS, INC.
To: UNICYCIVE THERAPEUTICS, INC.
Reel/Frame 056713/0060 →
Security Interest
Sep 22, 2022
From: SPECTRUM PHARMACEUTICALS, INC.; ALLOS THERAPEUTICS, INC.; TALON THERAPEUTICS, INC.
To: SLR INVESTMENT CORP., AS COLLATERAL AGENT
Reel/Frame 061179/0202 →
Termination and Release of Intellectual Property Security Agreement Recorded at Reel 061179/Frame 0202
Aug 1, 2023
From: SLR INVESTMENT CORP.
To: SPECTRUM PHARMACEUTICALS, INC.; ALLOS THERAPEUTICS, INC.; TALON THERAPEUTICS, INC.
Reel/Frame 064463/0709 →